Moehs Group, a reference company in the production of pharmaceutical active ingredients.
01 1Moehs Iberica
02 1Chiral Quest
03 1Cipla
04 1Curia
05 1Blank
01 4DEUCRAVACITINIB
02 1DEUCRAVACITINIB INTERMEDIATE-2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)ANILINE
01 1China
02 1India
03 1Spain
04 1U.S.A
05 1Blank
01 5Active
01 5Blank
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41294
Submission : 2025-02-12
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41638
Submission : 2025-03-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40962
Submission : 2025-03-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41626
Submission : 2025-03-28
Status : Active
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41452
Submission : 2025-03-28
Status : Active
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
93
PharmaCompass offers a list of Deucravacitinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Deucravacitinib manufacturer or Deucravacitinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Deucravacitinib manufacturer or Deucravacitinib supplier.
PharmaCompass also assists you with knowing the Deucravacitinib API Price utilized in the formulation of products. Deucravacitinib API Price is not always fixed or binding as the Deucravacitinib Price is obtained through a variety of data sources. The Deucravacitinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Deucravacitinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deucravacitinib, including repackagers and relabelers. The FDA regulates Deucravacitinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deucravacitinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Deucravacitinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Deucravacitinib supplier is an individual or a company that provides Deucravacitinib active pharmaceutical ingredient (API) or Deucravacitinib finished formulations upon request. The Deucravacitinib suppliers may include Deucravacitinib API manufacturers, exporters, distributors and traders.
click here to find a list of Deucravacitinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Deucravacitinib DMF (Drug Master File) is a document detailing the whole manufacturing process of Deucravacitinib active pharmaceutical ingredient (API) in detail. Different forms of Deucravacitinib DMFs exist exist since differing nations have different regulations, such as Deucravacitinib USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Deucravacitinib DMF submitted to regulatory agencies in the US is known as a USDMF. Deucravacitinib USDMF includes data on Deucravacitinib's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Deucravacitinib USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Deucravacitinib suppliers with USDMF on PharmaCompass.
We have 4 companies offering Deucravacitinib
Get in contact with the supplier of your choice:
